Investigational RSV vaccine protects cattle from respiratory diseases
A novel vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, protected cattle from respiratory syncytial virus (RSV)...
View ArticleOne-shot vaccine passes key preclinical test in newborn monkey models
Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.
View ArticleSerum Institute signs licensing agreement to commercialize St. Jude vaccine...
St. Jude Children's Research Hospital and the Serum Institute of India have signed a licensing agreement to complete development and commercialization of a St. Jude vaccine against the respiratory...
View ArticleCUMC researchers create new organoids that mimic features of full-sized lung
New lung "organoids"-tiny 3-D structures that mimic features of a full-sized lung- have been created from human pluripotent stem cells by researchers at Columbia University Medical Center. The team...
View ArticleScientists find new clues to how RSV causes disease
By age 2, most children have been infected with respiratory syncytial virus (RSV), which usually causes only mild cold symptoms. But people with weakened immune systems, such as infants and the...
View ArticleCommon viruses pose serious challenges in long-term care facilities
A widespread outbreak of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) at a long-term dementia care ward infected 73 percent of patients, demonstrating the serious challenges in...
View ArticleScientists discover critical role of biological molecule in protecting...
Scientists have discovered that a biological molecule important in cell growth (STAT3) is also critical in protecting us against infection - so much so that we would be unable to fight the common flu...
View ArticlePenn scientists find cytokine as key to fighting and treating viral infection...
Viral infections that occur in a patient's lungs are a significant cause of hospitalization and death among children and the elderly.
View ArticlePreterm babies given monoclonal antibody appear less likely to develop...
Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to...
View ArticleResearchers develop new antiviral strategy to combat respiratory syncytial virus
Researchers from VIB, UGent, the Geisel School of Medicine at Dartmouth and several collaborators developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cause of...
View ArticleInvestigational RSV vaccine protects cattle from respiratory diseases
A novel vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, protected cattle from respiratory syncytial virus (RSV)...
View ArticleOne-shot vaccine passes key preclinical test in newborn monkey models
Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.
View ArticleSerum Institute signs licensing agreement to commercialize St. Jude vaccine...
St. Jude Children's Research Hospital and the Serum Institute of India have signed a licensing agreement to complete development and commercialization of a St. Jude vaccine against the respiratory...
View ArticleCUMC researchers create new organoids that mimic features of full-sized lung
New lung "organoids"-tiny 3-D structures that mimic features of a full-sized lung- have been created from human pluripotent stem cells by researchers at Columbia University Medical Center. The team...
View ArticleScientists find new clues to how RSV causes disease
By age 2, most children have been infected with respiratory syncytial virus (RSV), which usually causes only mild cold symptoms. But people with weakened immune systems, such as infants and the...
View ArticleResearch highlights need for vaccines to prevent child deaths from fatal lung...
Vaccines to combat a virus that can lead to fatal lung infections are urgently needed to help prevent child deaths worldwide, research suggests.
View ArticleResearchers discover gene mutations that worsen respiratory infections among...
Researchers funded by the Swiss National Science Foundation have discovered mutations that worsen respiratory infections among children. Their study explains the mechanism involved.
View ArticleESCMID conference brings together renowned experts to address most pressing...
Registration is open for the 4th ESCMID Conference on Vaccines. New and old diseases in children and adults: unmet needs in Dubrovnik, Croatia, Friday 8 September to Sunday 10 September 2017....
View ArticleStudy offers solution to protect against vaccine-enhanced respiratory disease
Researchers have discovered that a virus-like particle vaccine can prime the body's immune response and prevent the severe respiratory disease that results when patients given an early form of a...
View ArticleEPFL scientists create gold nanoparticles to combat all viruses
HIV, dengue, papillomavirus, herpes and Ebola - these are just some of the many viruses that kill millions of people every year, mostly children in developing countries. While drugs can be used against...
View Article